Trials / Completed
CompletedNCT02848066
Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor Biomarker
Open, Parallel, Single-Site Study to Evaluate Sensitivity and Specificity of Newly Defined Diagnosed-biomarker for Gastric Cancer Pts and Cancer-free Healthy Volunteers
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 353 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate sensitivity and specificity of newly defined tumor biomarker with gastric cancer pts and cancer-free healthy volunteers.
Detailed description
Measurements of specific glycosylation changes in serum haptoglobin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood sample(10cc) collection | In both groups, serum haptoglobins to be collected and analyzed |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2016-08-01
- Completion
- 2017-09-01
- First posted
- 2016-07-28
- Last updated
- 2019-05-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02848066. Inclusion in this directory is not an endorsement.